SEC Form 4 · accession 0001104659-15-046030
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles W Newhall III
Director
Period of report
Jun 15, 2015
Accepted (ET)
Jun 17, 2015 · 7:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 15, 2015 | J | 26,012 | — | A | 26,012 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pro rata distribution of shares from NEA Partners 11, Limited Partnership of which the reporting person was a non-managing limited partner.